Avidity Biosciences, Inc. financial data

Symbol
RNA on Nasdaq
Industry
Pharmaceutical Preparations
Location
10578 Science Center Drive, Suite 125, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Avidity Biosciences LLC (to 1/6/2017), Avidity NanoMedicines LLC (to 2/18/2014)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.19K % +0.2%
Debt-to-equity 14 % +31.5%
Return On Equity -32.9 % +11.9%
Return On Assets -28.9 % +14.5%
Operating Margin -2.69K % -26.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 110M shares +48.2%
Common Stock, Shares, Outstanding 109M shares +47.5%
Entity Public Float 811M USD +9.78%
Common Stock, Value, Issued 11K USD +57.1%
Weighted Average Number of Shares Outstanding, Basic 107M shares +49.8%
Weighted Average Number of Shares Outstanding, Diluted 107M shares +49.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.6M USD +8.15%
Research and Development Expense 231M USD +33.4%
General and Administrative Expense 64.5M USD +43.9%
Operating Income (Loss) -285M USD -36.9%
Nonoperating Income (Expense) 32.7M USD +120%
Net Income (Loss) Attributable to Parent -252M USD -30.5%
Earnings Per Share, Basic -2.95 USD/shares +5.15%
Earnings Per Share, Diluted -2.95 USD/shares +5.15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 576M USD +274%
Marketable Securities, Current 262M USD +8582%
Cash, Cash Equivalents, and Short-term Investments 1.3B USD +125%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 5.86M USD
Assets, Current 1.33B USD +124%
Property, Plant and Equipment, Net 8.5M USD +9.29%
Operating Lease, Right-of-Use Asset 6.97M USD -10.2%
Other Assets, Noncurrent 364K USD -14.2%
Assets 1.35B USD +121%
Accounts Payable, Current 8.89M USD +57.2%
Contract with Customer, Liability, Current 26.7M USD +601%
Liabilities, Current 84.2M USD +86.1%
Contract with Customer, Liability, Noncurrent 37.6M USD
Operating Lease, Liability, Noncurrent 4.62M USD -27.4%
Liabilities 126M USD +145%
Accumulated Other Comprehensive Income (Loss), Net of Tax -453K USD +83%
Retained Earnings (Accumulated Deficit) -710M USD -55.1%
Stockholders' Equity Attributable to Parent 1.22B USD +118%
Liabilities and Equity 1.35B USD +121%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -70.4M USD -43.7%
Net Cash Provided by (Used in) Financing Activities 389M USD +1596%
Net Cash Provided by (Used in) Investing Activities -32.7M USD +83.3%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 109M shares +47.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 286M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 579M USD +275%
Deferred Tax Assets, Valuation Allowance 173M USD +55%
Deferred Tax Assets, Gross 175M USD +53.4%
Operating Lease, Liability 9.85M USD -7.81%
Depreciation 2.55M USD +53.3%
Payments to Acquire Property, Plant, and Equipment 915K USD -49.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -250M USD -29.5%
Lessee, Operating Lease, Liability, to be Paid 11.2M USD -12%
Property, Plant and Equipment, Gross 15M USD +27.3%
Operating Lease, Liability, Current 3.77M USD +19.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.85M USD +20.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.7M USD +19.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.34M USD -33.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.64M USD +10.4%
Deferred Tax Assets, Operating Loss Carryforwards 72.7M USD +27.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 40M shares 0%
Unrecognized Tax Benefits 11M USD +132%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.11M USD -5.81%
Operating Lease, Payments 0 USD
Additional Paid in Capital 939M USD +65.9%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.97M USD -20%
Share-based Payment Arrangement, Expense 42.8M USD +29.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%